25 XP   0   0   10

Ipsen SA
Buy, Hold or Sell?

Let's analyse Ipsen together

PenkeI guess you are interested in Ipsen SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ipsen SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ipsen SA

I send you an email if I find something interesting about Ipsen SA.

Quick analysis of Ipsen (30 sec.)










What can you expect buying and holding a share of Ipsen? (30 sec.)

How much money do you get?

How much money do you get?
€1.96
When do you have the money?
1 year
How often do you get paid?
76.9%

What is your share worth?

Current worth
€45.79
Expected worth in 1 year
€53.21
How sure are you?
51.3%

+ What do you gain per year?

Total Gains per Share
€9.26
Return On Investment
8.2%

For what price can you sell your share?

Current Price per Share
€113.00
Expected price per share
€110.50 - €130.70
How sure are you?
50%

1. Valuation of Ipsen (5 min.)




Live pricePrice per Share (EOD)

€113.00

Intrinsic Value Per Share

€134.89 - €275.89

Total Value Per Share

€180.68 - €321.68

2. Growth of Ipsen (5 min.)




Is Ipsen growing?

Current yearPrevious yearGrowGrow %
How rich?$4b$2.1b$1.6b42.7%

How much money is Ipsen making?

Current yearPrevious yearGrowGrow %
Making money$229.7m$173.1m$56.5m24.6%
Net Profit Margin13.4%10.4%--

How much money comes from the company's main activities?

3. Financial Health of Ipsen (5 min.)




What can you expect buying and holding a share of Ipsen? (5 min.)

Welcome investor! Ipsen's management wants to use your money to grow the business. In return you get a share of Ipsen.

What can you expect buying and holding a share of Ipsen?

First you should know what it really means to hold a share of Ipsen. And how you can make/lose money.

Speculation

The Price per Share of Ipsen is €113.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ipsen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ipsen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €45.79. Based on the TTM, the Book Value Change Per Share is €1.86 per quarter. Based on the YOY, the Book Value Change Per Share is €1.80 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.46 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ipsen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps5.755.1%2.762.4%2.091.8%1.651.5%1.201.1%
Usd Book Value Change Per Share5.154.6%1.991.8%1.921.7%1.331.2%0.930.8%
Usd Dividend Per Share0.000.0%0.490.4%0.380.3%0.300.3%0.270.2%
Usd Total Gains Per Share5.154.6%2.482.2%2.302.0%1.631.4%1.201.1%
Usd Price Per Share115.44-113.98-106.66-97.47-89.61-
Price to Earnings Ratio5.01-5.58-3.24-4.65-15.31-
Price-to-Total Gains Ratio22.40-37.10--0.49-3.88-1.69-
Price to Book Ratio2.36-2.52-6.44-7.05-8.94-
Price-to-Total Gains Ratio22.40-37.10--0.49-3.88-1.69-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share120.8987
Number of shares8
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.490.30
Usd Book Value Change Per Share1.991.33
Usd Total Gains Per Share2.481.63
Gains per Quarter (8 shares)19.8113.03
Gains per Year (8 shares)79.2552.12
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1166469104342
231127148198594
34719122729128146
46325430638170198
57831838548213250
69438146457256302
711044554367298354
812650862276341406
914157270186383458
1015763678095426510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.00.01.066.7%6.00.05.054.5%11.02.06.057.9%31.02.06.079.5%71.02.06.089.9%
Book Value Change Per Share2.00.01.066.7%6.04.01.054.5%10.08.01.052.6%20.018.01.051.3%35.026.018.044.3%
Dividend per Share1.00.02.033.3%4.00.07.036.4%10.00.09.052.6%30.00.09.076.9%70.00.09.088.6%
Total Gains per Share2.00.01.066.7%6.04.01.054.5%10.08.01.052.6%20.018.01.051.3%52.026.01.065.8%

Fundamentals of Ipsen

About Ipsen SA

Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. Its product pipeline comprises Cabometyx + Atezolizumab, which is in phase III clinical trial for the treatment of second line metastatic castration-resistant prostate cancer; lenalidomide and rituximab, and Taverik, which is in phase III for the treatment of second line follicular lymphoma; Bylvay, which is in phase III for the treatment of biliary atresia; Dysport, which is in phase III clinical trial for the treatment of chronic and episodic migraine; Fidrisertib, which is in phase II clinical trial for the treatment of fibrodysplasia ossificans progressiva; Elafibranor, which is in phase II for the treatment of primary sclerosing cholangitis, as well as IPN60250; IPN10200, which is in phase II for the treatment of longer-acting neurotoxin aesthetics and therapeutics; IPN60210, which is in phase I clinical trial for the treatment of relapsed/refractory multiple myeloma; and IPN60260 for the treatment of Viral cholestatic disease and is in phase I clinical trial. The company also offers Somatuline, Decapeptyl, Cabometyx, Onivyde, Tazverik, and other oncology products; Dysport and other neurosciences products; and Bylvay, NutropinAq, Increlex, and Sohonos for rare diseases. The company was founded in 1929 and is based in Boulogne-Billancourt, France.

Fundamental data was last updated by Penke on 2024-04-09 14:40:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Ipsen SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ipsen earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 28.2% means that €0.28 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ipsen SA:

  • The MRQ is 28.2%. The company is making a huge profit. +2
  • The TTM is 13.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ28.2%TTM13.4%+14.8%
TTM13.4%YOY10.4%+3.0%
TTM13.4%5Y10.8%+2.6%
5Y10.8%10Y12.2%-1.4%
1.1.2. Return on Assets

Shows how efficient Ipsen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • 7.1% Return on Assets means that Ipsen generated €0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ipsen SA:

  • The MRQ is 7.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 3.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.1%TTM3.4%+3.7%
TTM3.4%YOY2.9%+0.5%
TTM3.4%5Y2.9%+0.5%
5Y2.9%10Y4.5%-1.6%
1.1.3. Return on Equity

Shows how efficient Ipsen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • 11.7% Return on Equity means Ipsen generated €0.12 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ipsen SA:

  • The MRQ is 11.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.7%TTM5.8%+5.9%
TTM5.8%YOY5.1%+0.7%
TTM5.8%5Y5.4%+0.4%
5Y5.4%10Y8.1%-2.7%

1.2. Operating Efficiency of Ipsen SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ipsen is operating .

  • Measures how much profit Ipsen makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 29.6% means the company generated €0.30  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ipsen SA:

  • The MRQ is 29.6%. The company is operating very efficient. +2
  • The TTM is 16.5%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ29.6%TTM16.5%+13.1%
TTM16.5%YOY14.0%+2.6%
TTM16.5%5Y19.6%-3.0%
5Y19.6%10Y18.7%+0.9%
1.2.2. Operating Ratio

Measures how efficient Ipsen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.70 means that the operating costs are €0.70 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Ipsen SA:

  • The MRQ is 0.704. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.501. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.704TTM0.501+0.203
TTM0.501YOY0.360+0.141
TTM0.5015Y0.187+0.314
5Y0.18710Y0.356-0.169

1.3. Liquidity of Ipsen SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ipsen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.17 means the company has €1.17 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Ipsen SA:

  • The MRQ is 1.167. The company is just able to pay all its short-term debts.
  • The TTM is 0.732. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ1.167TTM0.732+0.435
TTM0.732YOY1.818-1.085
TTM0.7325Y1.278-0.546
5Y1.27810Y1.411-0.133
1.3.2. Quick Ratio

Measures if Ipsen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.78 means the company can pay off €0.78 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ipsen SA:

  • The MRQ is 0.785. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.501. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.785TTM0.501+0.284
TTM0.501YOY1.684-1.183
TTM0.5015Y0.929-0.428
5Y0.92910Y0.894+0.034

1.4. Solvency of Ipsen SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ipsen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ipsen to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.40 means that Ipsen assets are financed with 39.5% credit (debt) and the remaining percentage (100% - 39.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ipsen SA:

  • The MRQ is 0.395. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.414. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.395TTM0.414-0.019
TTM0.414YOY0.415-0.001
TTM0.4145Y0.483-0.069
5Y0.48310Y0.456+0.026
1.4.2. Debt to Equity Ratio

Measures if Ipsen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 65.3% means that company has €0.65 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ipsen SA:

  • The MRQ is 0.653. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.708. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.653TTM0.708-0.054
TTM0.708YOY0.710-0.002
TTM0.7085Y0.973-0.265
5Y0.97310Y0.872+0.102

2. Market Valuation of Ipsen SA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Ipsen generates.

  • Above 15 is considered overpriced but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 5.01 means the investor is paying €5.01 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ipsen SA:

  • The EOD is 5.252. Based on the earnings, the company is cheap. +2
  • The MRQ is 5.015. Based on the earnings, the company is cheap. +2
  • The TTM is 5.579. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD5.252MRQ5.015+0.237
MRQ5.015TTM5.579-0.565
TTM5.579YOY3.237+2.343
TTM5.5795Y4.651+0.928
5Y4.65110Y15.309-10.658
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ipsen SA:

  • The EOD is 7.405. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.071. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 3.980. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.405MRQ7.071+0.334
MRQ7.071TTM3.980+3.091
TTM3.980YOY1.869+2.111
TTM3.9805Y4.125-0.145
5Y4.12510Y7.511-3.386
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ipsen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.36 means the investor is paying €2.36 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Ipsen SA:

  • The EOD is 2.468. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.356. Based on the equity, the company is underpriced. +1
  • The TTM is 2.523. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.468MRQ2.356+0.111
MRQ2.356TTM2.523-0.167
TTM2.523YOY6.437-3.914
TTM2.5235Y7.049-4.526
5Y7.04910Y8.944-1.895
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Ipsen SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--4.8171.856+159%1.795+168%1.245+287%0.874+451%
Book Value Per Share--45.78942.327+8%24.273+89%21.997+108%15.980+187%
Current Ratio--1.1670.732+59%1.818-36%1.278-9%1.411-17%
Debt To Asset Ratio--0.3950.414-4%0.415-5%0.483-18%0.456-13%
Debt To Equity Ratio--0.6530.708-8%0.710-8%0.973-33%0.872-25%
Dividend Per Share---0.458-100%0.353-100%0.278-100%0.248-100%
Eps--5.3792.576+109%1.951+176%1.540+249%1.124+379%
Free Cash Flow Per Share--3.8154.737-19%6.429-41%4.373-13%2.814+36%
Free Cash Flow To Equity Per Share--0.9382.033-54%5.439-83%3.142-70%2.167-57%
Gross Profit Margin--1.000-0.092+109%-0.184+118%3.096-68%0.995+1%
Intrinsic Value_10Y_max--275.887--------
Intrinsic Value_10Y_min--134.894--------
Intrinsic Value_1Y_max--23.643--------
Intrinsic Value_1Y_min--11.717--------
Intrinsic Value_3Y_max--74.088--------
Intrinsic Value_3Y_min--36.972--------
Intrinsic Value_5Y_max--128.212--------
Intrinsic Value_5Y_min--63.972--------
Market Cap9344568448.000+4%9010864090.8008861715712.200+2%8295944866.475+9%7592426387.332+19%6962706584.066+29%
Net Profit Margin--0.2820.134+110%0.104+172%0.108+161%0.122+132%
Operating Margin--0.2960.165+79%0.140+112%0.196+51%0.187+58%
Operating Ratio--0.7040.501+40%0.360+95%0.187+276%0.356+98%
Pb Ratio2.468+5%2.3562.523-7%6.437-63%7.049-67%8.944-74%
Pe Ratio5.252+5%5.0155.579-10%3.237+55%4.651+8%15.309-67%
Price Per Share113.000+5%107.900106.533+1%99.688+8%91.098+18%83.751+29%
Price To Free Cash Flow Ratio7.405+5%7.0713.980+78%1.869+278%4.125+71%7.511-6%
Price To Total Gains Ratio23.459+5%22.40037.101-40%-0.485+102%3.881+477%1.691+1225%
Quick Ratio--0.7850.501+57%1.684-53%0.929-16%0.894-12%
Return On Assets--0.0710.034+107%0.029+143%0.029+143%0.045+57%
Return On Equity--0.1170.058+102%0.051+130%0.054+116%0.081+45%
Total Gains Per Share--4.8172.315+108%2.149+124%1.522+216%1.122+329%
Usd Book Value--4091190610.0003767438870.000+9%2158830846.250+90%1960127188.158+109%1421404671.667+188%
Usd Book Value Change Per Share--5.1541.986+159%1.921+168%1.331+287%0.935+451%
Usd Book Value Per Share--48.99045.286+8%25.970+89%23.534+108%17.097+187%
Usd Dividend Per Share---0.490-100%0.378-100%0.297-100%0.265-100%
Usd Eps--5.7552.756+109%2.088+176%1.647+249%1.202+379%
Usd Free Cash Flow--340870140.000281241046.667+21%285663300.000+19%266737332.105+28%211857345.833+61%
Usd Free Cash Flow Per Share--4.0825.068-19%6.878-41%4.679-13%3.011+36%
Usd Free Cash Flow To Equity Per Share--1.0032.175-54%5.819-83%3.361-70%2.318-57%
Usd Market Cap9997753782.515+4%9640723490.7479481149640.483+2%8875831412.642+9%8123136991.806+19%7449399774.292+29%
Usd Price Per Share120.899+5%115.442113.980+1%106.656+8%97.466+18%89.605+29%
Usd Profit--480599080.000229778856.667+109%173190062.500+177%139627581.053+244%101469041.667+374%
Usd Revenue--1702103910.0001146219533.333+48%844284837.500+102%792676240.132+115%628193842.500+171%
Usd Total Gains Per Share--5.1542.477+108%2.299+124%1.629+216%1.200+329%
 EOD+4 -4MRQTTM+26 -10YOY+24 -125Y+23 -1310Y+28 -8

3.2. Fundamental Score

Let's check the fundamental score of Ipsen SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-155.252
Price to Book Ratio (EOD)Between0-12.468
Net Profit Margin (MRQ)Greater than00.282
Operating Margin (MRQ)Greater than00.296
Quick Ratio (MRQ)Greater than10.785
Current Ratio (MRQ)Greater than11.167
Debt to Asset Ratio (MRQ)Less than10.395
Debt to Equity Ratio (MRQ)Less than10.653
Return on Equity (MRQ)Greater than0.150.117
Return on Assets (MRQ)Greater than0.050.071
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Ipsen SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.467
Ma 20Greater thanMa 50109.210
Ma 50Greater thanMa 100106.822
Ma 100Greater thanMa 200106.229
OpenGreater thanClose112.600
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets6,322,900
Total Liabilities2,499,000
Total Stockholder Equity3,825,100
 As reported
Total Liabilities 2,499,000
Total Stockholder Equity+ 3,825,100
Total Assets = 6,322,900

Assets

Total Assets6,322,900
Total Current Assets1,898,400
Long-term Assets4,424,500
Total Current Assets
Cash And Cash Equivalents 528,400
Short-term Investments 10,600
Net Receivables 737,500
Inventory 289,500
Other Current Assets 343,000
Total Current Assets  (as reported)1,898,400
Total Current Assets  (calculated)1,909,000
+/- 10,600
Long-term Assets
Property Plant Equipment 574,600
Goodwill 663,900
Intangible Assets 3,342,700
Long-term Assets  (as reported)4,424,500
Long-term Assets  (calculated)4,581,200
+/- 156,700

Liabilities & Shareholders' Equity

Total Current Liabilities1,626,800
Long-term Liabilities872,200
Total Stockholder Equity3,825,100
Total Current Liabilities
Short-term Debt 134,100
Short Long Term Debt 9,000
Accounts payable 771,400
Other Current Liabilities 679,900
Total Current Liabilities  (as reported)1,626,800
Total Current Liabilities  (calculated)1,594,400
+/- 32,400
Long-term Liabilities
Long-term Liabilities Other 247,300
Long-term Liabilities  (as reported)872,200
Long-term Liabilities  (calculated)247,300
+/- 624,900
Total Stockholder Equity
Common Stock83,800
Retained Earnings 644,400
Accumulated Other Comprehensive Income 3,096,900
Total Stockholder Equity (as reported)3,825,100
Total Stockholder Equity (calculated)3,825,100
+/-0
Other
Capital Stock83,800
Cash and Short Term Investments 528,400
Common Stock Shares Outstanding 83,511
Current Deferred Revenue41,400
Liabilities and Stockholders Equity 6,322,900
Net Debt -52,900
Net Invested Capital 3,834,100
Net Working Capital 271,600
Short Long Term Debt Total 475,500



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312002-12-31
> Total Assets 
662,333
665,896
154,928
154,928
154,928
154,928
235,627
235,627
235,627
235,627
303,568
303,568
303,568
303,568
330,731
330,731
330,731
330,731
392,460
392,460
392,460
392,460
394,217
394,217
394,217
1,576,868
419,549
1,705,475
419,549
1,678,194
408,348
1,675,500
408,348
1,633,391
390,272
1,635,400
390,272
1,561,088
391,333
1,571,437
391,333
1,565,332
428,325
1,629,800
428,325
1,713,300
484,500
1,760,800
484,500
1,938,000
605,875
2,253,000
605,875
2,423,500
768,000
2,967,000
768,000
3,072,000
844,350
3,295,500
844,350
3,377,400
1,076,725
4,804,600
1,076,725
4,306,900
1,079,300
4,229,800
1,079,300
4,317,200
1,251,700
4,521,500
1,251,700
5,006,800
1,401,975
5,507,100
1,401,975
5,607,900
0
6,090,600
6,322,900
6,322,9006,090,60005,607,9001,401,9755,507,1001,401,9755,006,8001,251,7004,521,5001,251,7004,317,2001,079,3004,229,8001,079,3004,306,9001,076,7254,804,6001,076,7253,377,400844,3503,295,500844,3503,072,000768,0002,967,000768,0002,423,500605,8752,253,000605,8751,938,000484,5001,760,800484,5001,713,300428,3251,629,800428,3251,565,332391,3331,571,437391,3331,561,088390,2721,635,400390,2721,633,391408,3481,675,500408,3481,678,194419,5491,705,475419,5491,576,868394,217394,217394,217392,460392,460392,460392,460330,731330,731330,731330,731303,568303,568303,568303,568235,627235,627235,627235,627154,928154,928154,928154,928665,896662,333
   > Total Current Assets 
0
0
72,750
72,750
72,750
72,750
126,920
126,920
126,920
126,920
152,941
152,941
152,941
152,941
159,203
159,203
159,203
159,203
172,266
172,266
172,266
172,266
163,091
163,091
163,091
652,362
159,945
610,592
159,945
639,778
158,188
624,500
158,188
632,750
151,587
584,800
151,587
606,349
150,461
651,888
150,461
601,845
167,900
651,400
167,900
671,600
202,475
672,600
202,475
809,900
262,600
964,000
262,600
1,050,400
254,100
925,300
254,100
1,016,400
296,400
1,180,200
296,400
1,185,600
336,625
1,221,400
336,625
1,346,500
394,700
1,411,100
394,700
1,578,800
488,450
1,764,200
488,450
1,953,800
599,400
2,589,000
599,400
2,397,600
0
1,759,800
1,898,400
1,898,4001,759,80002,397,600599,4002,589,000599,4001,953,800488,4501,764,200488,4501,578,800394,7001,411,100394,7001,346,500336,6251,221,400336,6251,185,600296,4001,180,200296,4001,016,400254,100925,300254,1001,050,400262,600964,000262,600809,900202,475672,600202,475671,600167,900651,400167,900601,845150,461651,888150,461606,349151,587584,800151,587632,750158,188624,500158,188639,778159,945610,592159,945652,362163,091163,091163,091172,266172,266172,266172,266159,203159,203159,203159,203152,941152,941152,941152,941126,920126,920126,920126,92072,75072,75072,75072,75000
       Cash And Cash Equivalents 
0
0
4,825
4,825
4,825
4,825
50,509
50,509
50,509
50,509
71,365
71,365
71,365
71,365
61,767
61,767
61,767
61,767
59,896
59,896
59,896
59,896
54,646
54,646
54,646
218,584
44,530
167,263
44,530
178,118
36,252
159,600
36,252
145,007
28,410
84,800
28,410
113,641
32,740
121,207
32,740
130,958
46,575
131,900
46,575
186,300
56,525
92,900
56,525
226,100
106,375
377,600
106,375
425,500
57,000
200,600
57,000
228,000
86,125
359,300
86,125
344,500
88,325
213,200
88,325
353,300
160,625
430,000
160,625
642,500
203,675
737,500
203,675
814,700
292,325
1,068,300
292,325
1,169,300
0
413,400
528,400
528,400413,40001,169,300292,3251,068,300292,325814,700203,675737,500203,675642,500160,625430,000160,625353,30088,325213,20088,325344,50086,125359,30086,125228,00057,000200,60057,000425,500106,375377,600106,375226,10056,52592,90056,525186,30046,575131,90046,575130,95832,740121,20732,740113,64128,41084,80028,410145,00736,252159,60036,252178,11844,530167,26344,530218,58454,64654,64654,64659,89659,89659,89659,89661,76761,76761,76761,76771,36571,36571,36571,36550,50950,50950,50950,5094,8254,8254,8254,82500
       Short-term Investments 
0
0
0
0
0
0
5
5
5
5
225
225
225
225
0
0
0
0
632
632
632
632
291
291
291
1,162
12
88
12
49
2
600
2
9
129
1,100
129
516
38
1,587
38
150
25
100
25
100
1,700
6,100
1,700
6,800
1,650
4,200
1,650
6,600
7,400
12,100
7,400
29,600
1,375
16,500
1,375
5,500
14,825
53,300
14,825
59,300
12,225
57,700
12,225
48,900
10,600
2,100
10,600
42,400
7,750
46,100
7,750
31,000
0
24,700
10,600
10,60024,700031,0007,75046,1007,75042,40010,6002,10010,60048,90012,22557,70012,22559,30014,82553,30014,8255,5001,37516,5001,37529,6007,40012,1007,4006,6001,6504,2001,6506,8001,7006,1001,7001002510025150381,587385161291,100129926002491288121,16229129129163263263263200002252252252255555000000
       Net Receivables 
152,683
170,556
0
0
0
185,558
0
177,298
0
175,632
0
195,903
0
225,211
0
0
0
242,783
0
298,075
0
315,673
0
306,465
0
279,071
0
273,612
0
286,545
0
285,900
0
298,500
0
303,500
0
341,760
0
386,210
0
336,021
0
339,400
0
379,900
0
381,200
0
445,700
0
389,200
0
494,500
0
445,200
0
591,500
0
497,900
0
510,700
0
602,100
0
720,000
0
569,700
0
559,800
0
765,100
0
877,400
0
797,700
673,700
781,300
0
790,300
737,500
737,500790,3000781,300673,700797,7000877,4000765,1000559,8000569,7000720,0000602,1000510,7000497,9000591,5000445,2000494,5000389,2000445,7000381,2000379,9000339,4000336,0210386,2100341,7600303,5000298,5000285,9000286,5450273,6120279,0710306,4650315,6730298,0750242,783000225,2110195,9030175,6320177,2980185,558000170,556152,683
       Other Current Assets 
15,201
14,035
51,654
51,654
51,654
51,654
57,810
57,810
57,810
57,810
61,615
61,615
61,615
61,615
75,658
75,658
75,658
75,658
82,752
82,752
82,752
82,752
82,412
82,412
82,412
50,575
87,366
61,546
87,366
62,917
92,475
62,300
92,475
71,400
91,084
73,800
91,084
364,335
87,319
9,450
87,319
13,253
94,925
72,000
94,925
-200
117,400
84,600
117,400
23,900
126,250
80,300
126,250
10,500
147,850
115,200
147,850
-100
159,275
118,200
159,275
126,400
179,975
155,600
179,975
-100
168,375
132,800
168,375
113,700
219,325
28,900
219,325
-100
228,300
532,900
228,300
162,900
0
206,100
343,000
343,000206,1000162,900228,300532,900228,300-100219,32528,900219,325113,700168,375132,800168,375-100179,975155,600179,975126,400159,275118,200159,275-100147,850115,200147,85010,500126,25080,300126,25023,900117,40084,600117,400-20094,92572,00094,92513,25387,3199,45087,319364,33591,08473,80091,08471,40092,47562,30092,47562,91787,36661,54687,36650,57582,41282,41282,41282,75282,75282,75282,75275,65875,65875,65875,65861,61561,61561,61561,61557,81057,81057,81057,81051,65451,65451,65451,65414,03515,201
   > Long-term Assets 
0
0
82,178
82,178
82,178
82,178
108,707
108,707
108,707
108,707
150,627
150,627
150,627
150,627
171,528
171,528
171,528
171,528
220,195
220,195
220,195
220,195
231,127
231,127
231,127
924,506
259,604
1,094,883
259,604
1,038,416
250,160
1,051,000
250,160
1,000,641
238,685
1,050,600
238,685
954,739
240,872
919,549
240,872
963,487
260,425
978,400
260,425
1,041,700
282,025
1,088,200
282,025
1,128,100
343,275
1,288,900
343,275
1,373,100
513,900
2,041,700
513,900
2,055,600
547,950
2,115,300
547,950
2,191,800
740,100
3,583,200
740,100
2,960,400
684,600
2,818,800
684,600
2,738,400
763,250
2,757,300
763,250
3,053,000
802,575
2,918,100
802,575
3,210,300
0
4,330,800
4,424,500
4,424,5004,330,80003,210,300802,5752,918,100802,5753,053,000763,2502,757,300763,2502,738,400684,6002,818,800684,6002,960,400740,1003,583,200740,1002,191,800547,9502,115,300547,9502,055,600513,9002,041,700513,9001,373,100343,2751,288,900343,2751,128,100282,0251,088,200282,0251,041,700260,425978,400260,425963,487240,872919,549240,872954,739238,6851,050,600238,6851,000,641250,1601,051,000250,1601,038,416259,6041,094,883259,604924,506231,127231,127231,127220,195220,195220,195220,195171,528171,528171,528171,528150,627150,627150,627150,627108,707108,707108,707108,70782,17882,17882,17882,17800
       Property Plant Equipment 
161,462
157,354
38,197
38,197
38,197
38,197
46,942
46,942
46,942
46,942
49,547
49,547
49,547
49,547
55,473
55,473
55,473
55,473
59,465
59,465
59,465
59,465
62,493
62,493
62,493
249,972
70,572
264,186
70,572
282,287
67,932
275,200
67,932
271,728
70,445
291,700
70,445
281,781
71,871
275,446
71,871
287,483
77,400
296,000
77,400
309,600
87,175
336,900
87,175
348,700
94,750
350,600
94,750
379,000
104,725
382,800
104,725
418,900
118,625
427,700
118,625
474,500
169,825
664,700
169,825
679,300
161,650
654,200
161,650
646,600
161,875
645,700
161,875
647,500
145,350
585,900
145,350
581,400
0
571,600
574,600
574,600571,6000581,400145,350585,900145,350647,500161,875645,700161,875646,600161,650654,200161,650679,300169,825664,700169,825474,500118,625427,700118,625418,900104,725382,800104,725379,00094,750350,60094,750348,70087,175336,90087,175309,60077,400296,00077,400287,48371,871275,44671,871281,78170,445291,70070,445271,72867,932275,20067,932282,28770,572264,18670,572249,97262,49362,49362,49359,46559,46559,46559,46555,47355,47355,47355,47349,54749,54749,54749,54746,94246,94246,94246,94238,19738,19738,19738,197157,354161,462
       Goodwill 
141,777
135,321
36,422
36,422
36,422
36,422
49,875
49,875
49,875
49,875
49,935
49,935
49,935
49,935
47,253
47,253
47,253
47,253
87,934
87,934
87,934
87,934
72,559
72,559
72,559
290,236
74,776
306,541
74,776
299,105
0
290,700
0
299,547
74,550
304,000
74,550
298,198
77,680
299,270
77,680
310,720
81,150
312,300
81,150
324,600
88,350
336,800
88,350
353,400
89,275
350,000
89,275
357,100
97,275
396,700
97,275
389,100
98,900
392,100
98,900
395,600
158,175
622,400
158,175
632,700
148,225
627,500
148,225
592,900
155,775
604,500
155,775
623,100
144,975
557,400
144,975
579,900
0
681,000
663,900
663,900681,0000579,900144,975557,400144,975623,100155,775604,500155,775592,900148,225627,500148,225632,700158,175622,400158,175395,60098,900392,10098,900389,10097,275396,70097,275357,10089,275350,00089,275353,40088,350336,80088,350324,60081,150312,30081,150310,72077,680299,27077,680298,19874,550304,00074,550299,5470290,7000299,10574,776306,54174,776290,23672,55972,55972,55987,93487,93487,93487,93447,25347,25347,25347,25349,93549,93549,93549,93549,87549,87549,87549,87536,42236,42236,42236,422135,321141,777
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,000
0
175,800
0
165,800
0
169,300
0
173,600
0
171,100
0
111,400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000111,4000171,1000173,6000169,3000165,8000175,800037,00000000000000000000000000000000000000000000000000000000
       Intangible Assets 
145,222
152,587
3,762
3,762
3,762
3,762
7,284
7,284
7,284
7,284
14,325
14,325
14,325
14,325
22,292
22,292
22,292
22,292
40,978
40,978
40,978
40,978
59,242
59,242
59,242
236,967
41,635
264,073
41,635
166,538
0
182,700
0
430,931
32,294
142,000
32,294
129,175
36,197
112,364
36,197
144,787
40,150
142,400
40,150
160,600
37,800
105,700
37,800
151,200
95,025
326,800
95,025
380,100
232,525
899,000
232,525
930,100
253,000
963,600
253,000
1,012,000
345,725
1,949,600
345,725
1,382,900
280,325
1,247,300
280,325
1,121,300
347,975
1,142,500
347,975
1,391,900
396,350
1,930,500
396,350
2,165,300
0
3,228,900
3,342,700
3,342,7003,228,90002,165,300396,3501,930,500396,3501,391,900347,9751,142,500347,9751,121,300280,3251,247,300280,3251,382,900345,7251,949,600345,7251,012,000253,000963,600253,000930,100232,525899,000232,525380,10095,025326,80095,025151,20037,800105,70037,800160,60040,150142,40040,150144,78736,197112,36436,197129,17532,294142,00032,294430,9310182,7000166,53841,635264,07341,635236,96759,24259,24259,24240,97840,97840,97840,97822,29222,29222,29222,29214,32514,32514,32514,3257,2847,2847,2847,2843,7623,7623,7623,762152,587145,222
       Long-term Assets Other 
0
0
1,112
1,112
1,112
1,112
668
668
668
668
7,650
7,650
7,650
7,650
20,924
20,924
20,924
20,924
3,958
3,958
3,958
3,958
5,742
5,742
5,742
20,746
22,744
42,793
22,744
81,692
24,226
81,100
24,226
93,988
9,356
112,800
9,356
11,553
4,491
12,465
4,491
9,440
7,150
8,400
7,150
8,700
10,300
20,600
10,300
15,700
7,025
14,900
7,025
13,300
40,200
18,200
40,200
34,400
40,575
21,200
40,575
9,700
24,325
60,300
24,325
64,000
27,775
63,100
27,775
52,500
27,800
4,800
27,800
46,700
29,025
-553,000
29,025
-573,700
0
-610,200
-613,200
-613,200-610,2000-573,70029,025-553,00029,02546,70027,8004,80027,80052,50027,77563,10027,77564,00024,32560,30024,3259,70040,57521,20040,57534,40040,20018,20040,20013,3007,02514,9007,02515,70010,30020,60010,3008,7007,1508,4007,1509,4404,49112,4654,49111,5539,356112,8009,35693,98824,22681,10024,22681,69222,74442,79322,74420,7465,7425,7425,7423,9583,9583,9583,95820,92420,92420,92420,9247,6507,6507,6507,6506686686686681,1121,1121,1121,11200
> Total Liabilities 
434,379
354,243
105,496
105,496
105,496
105,496
80,352
80,352
80,352
80,352
121,592
121,592
121,592
121,592
130,453
130,453
130,453
130,453
175,339
175,339
175,339
175,339
148,130
148,130
148,130
592,520
149,741
628,772
149,741
598,964
154,492
600,500
154,492
617,966
158,709
580,300
158,709
634,837
147,898
631,786
147,898
591,593
161,350
647,000
161,350
645,400
178,100
626,200
178,100
712,400
265,325
994,900
265,325
1,061,300
384,025
1,559,000
384,025
1,536,100
383,500
1,627,700
383,500
1,534,000
638,475
2,821,300
638,475
2,553,900
548,850
2,370,400
548,850
2,195,400
563,200
2,133,200
563,200
2,252,800
567,800
2,441,000
567,800
2,271,200
0
2,687,300
2,499,000
2,499,0002,687,30002,271,200567,8002,441,000567,8002,252,800563,2002,133,200563,2002,195,400548,8502,370,400548,8502,553,900638,4752,821,300638,4751,534,000383,5001,627,700383,5001,536,100384,0251,559,000384,0251,061,300265,325994,900265,325712,400178,100626,200178,100645,400161,350647,000161,350591,593147,898631,786147,898634,837158,709580,300158,709617,966154,492600,500154,492598,964149,741628,772149,741592,520148,130148,130148,130175,339175,339175,339175,339130,453130,453130,453130,453121,592121,592121,592121,59280,35280,35280,35280,352105,496105,496105,496105,496354,243434,379
   > Total Current Liabilities 
228,277
175,408
52,514
52,514
52,514
52,514
62,624
62,624
62,624
62,624
67,352
67,352
67,352
67,352
68,677
68,677
68,677
68,677
79,013
79,013
79,013
79,013
77,002
77,002
77,002
308,007
83,093
295,925
83,093
332,373
92,603
347,900
92,603
370,410
109,241
335,700
109,241
436,963
94,060
372,939
94,060
376,241
102,550
350,600
102,550
410,200
115,375
374,300
115,375
461,500
140,325
432,700
140,325
561,300
235,450
921,600
235,450
941,800
239,800
1,054,400
239,800
959,200
363,125
1,669,800
363,125
1,452,500
303,275
1,334,900
303,275
1,213,100
307,100
1,117,000
307,100
1,228,400
333,850
1,374,200
333,850
1,335,400
0
1,709,800
1,626,800
1,626,8001,709,80001,335,400333,8501,374,200333,8501,228,400307,1001,117,000307,1001,213,100303,2751,334,900303,2751,452,500363,1251,669,800363,125959,200239,8001,054,400239,800941,800235,450921,600235,450561,300140,325432,700140,325461,500115,375374,300115,375410,200102,550350,600102,550376,24194,060372,93994,060436,963109,241335,700109,241370,41092,603347,90092,603332,37383,093295,92583,093308,00777,00277,00277,00279,01379,01379,01379,01368,67768,67768,67768,67767,35267,35267,35267,35262,62462,62462,62462,62452,51452,51452,51452,514175,408228,277
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,183
0
7,160
0
4,190
0
10,400
0
4,176
0
4,600
0
4,353
0
7,608
0
9,603
0
6,900
0
10,100
0
9,100
0
16,100
0
22,100
0
7,000
0
122,400
0
64,700
0
18,500
0
37,700
0
828,400
0
285,100
0
307,800
0
231,700
0
191,900
0
35,300
0
351,600
0
104,600
0
329,800
134,100
134,100329,8000104,6000351,600035,3000191,9000231,7000307,8000285,1000828,400037,700018,500064,7000122,40007,000022,100016,10009,100010,10006,90009,60307,60804,35304,60004,176010,40004,19007,160017,1830000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
375,100
0
870,100
0
273,600
0
28,000
0
167,700
0
828,400
0
285,100
0
277,000
0
2,800
0
161,800
0
5,500
0
30,600
0
3,800
0
1,200
9,000
9,0001,20003,800030,60005,5000161,80002,8000277,0000285,1000828,4000167,700028,0000273,6000870,1000375,10000000000000000000000000000000000000000000000000000000
       Accounts payable 
97,307
85,805
24,986
24,986
24,986
24,986
26,761
26,761
26,761
26,761
25,067
25,067
25,067
25,067
26,045
26,045
26,045
26,045
25,959
25,959
25,959
25,959
30,662
30,662
30,662
122,647
35,168
120,168
35,168
140,671
37,451
130,400
37,451
149,805
39,950
141,100
39,950
159,799
38,712
138,296
38,712
154,848
44,950
148,400
44,950
179,800
48,775
172,500
48,775
195,100
60,375
194,700
60,375
241,500
79,775
264,100
79,775
319,100
94,950
325,200
94,950
379,800
127,125
394,200
127,125
508,500
123,800
475,800
123,800
495,200
148,675
518,600
148,675
594,700
161,775
577,800
161,775
647,100
0
746,600
771,400
771,400746,6000647,100161,775577,800161,775594,700148,675518,600148,675495,200123,800475,800123,800508,500127,125394,200127,125379,80094,950325,20094,950319,10079,775264,10079,775241,50060,375194,70060,375195,10048,775172,50048,775179,80044,950148,40044,950154,84838,712138,29638,712159,79939,950141,10039,950149,80537,451130,40037,451140,67135,168120,16835,168122,64730,66230,66230,66225,95925,95925,95925,95926,04526,04526,04526,04525,06725,06725,06725,06726,76126,76126,76126,76124,98624,98624,98624,98685,80597,307
       Other Current Liabilities 
70,043
84,554
27,528
27,528
27,528
27,528
35,862
35,862
35,862
35,862
42,285
42,285
42,285
42,285
42,632
42,632
42,632
42,632
53,054
53,054
53,054
53,054
46,340
46,340
46,340
157,338
47,926
155,248
47,926
173,085
55,151
151,400
55,151
181,345
69,291
157,300
69,291
66,142
55,348
47,021
55,348
38,003
57,600
166,800
57,600
35,600
66,600
176,500
66,600
43,300
79,950
170,600
79,950
50,700
155,675
190,800
155,675
79,300
144,850
270,800
144,850
269,600
236,000
246,100
236,000
244,100
179,475
66,500
179,475
208,900
158,425
30,500
158,425
598,400
172,075
437,900
172,075
578,500
0
623,600
679,900
679,900623,6000578,500172,075437,900172,075598,400158,42530,500158,425208,900179,47566,500179,475244,100236,000246,100236,000269,600144,850270,800144,85079,300155,675190,800155,67550,70079,950170,60079,95043,30066,600176,50066,60035,60057,600166,80057,60038,00355,34847,02155,34866,14269,291157,30069,291181,34555,151151,40055,151173,08547,926155,24847,926157,33846,34046,34046,34053,05453,05453,05453,05442,63242,63242,63242,63242,28542,28542,28542,28535,86235,86235,86235,86227,52827,52827,52827,52884,55470,043
   > Long-term Liabilities 
0
0
52,982
52,982
52,982
52,982
17,729
17,729
17,729
17,729
54,240
54,240
54,240
54,240
61,777
61,777
61,777
61,777
96,326
96,326
96,326
96,326
71,128
71,128
71,128
284,513
66,648
332,847
66,648
266,591
61,889
252,600
61,889
247,556
49,469
244,600
49,469
197,874
53,838
258,847
53,838
215,352
58,800
296,400
58,800
235,200
62,725
251,900
62,725
250,900
125,000
562,200
125,000
500,000
148,575
637,400
148,575
594,300
143,700
573,300
143,700
574,800
275,350
1,151,500
275,350
1,101,400
245,575
1,035,500
245,575
982,300
256,100
1,016,200
256,100
1,024,400
233,950
1,066,800
233,950
935,800
0
977,500
872,200
872,200977,5000935,800233,9501,066,800233,9501,024,400256,1001,016,200256,100982,300245,5751,035,500245,5751,101,400275,3501,151,500275,350574,800143,700573,300143,700594,300148,575637,400148,575500,000125,000562,200125,000250,90062,725251,90062,725235,20058,800296,40058,800215,35253,838258,84753,838197,87449,469244,60049,469247,55661,889252,60061,889266,59166,648332,84766,648284,51371,12871,12871,12896,32696,32696,32696,32661,77761,77761,77761,77754,24054,24054,24054,24017,72917,72917,72917,72952,98252,98252,98252,98200
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
639,100
0
640,800
0
772,200
0
671,800
0
667,000
0
351,900
0
0351,9000667,0000671,8000772,2000640,8000639,100000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-17,183
0
-7,160
0
-4,190
0
-10,400
0
-4,176
0
-4,600
0
-4,353
0
-7,608
0
-9,603
0
-6,900
0
-10,100
0
-9,100
0
-16,100
0
-22,100
0
-7,000
0
-122,400
0
-64,700
0
-18,500
0
-37,700
0
-828,400
0
-285,100
0
-166,600
0
-105,400
0
-71,200
0
89,500
0
-234,800
0
5,100
0
-329,800
-134,100
-134,100-329,80005,1000-234,800089,5000-71,2000-105,4000-166,6000-285,1000-828,4000-37,7000-18,5000-64,7000-122,4000-7,0000-22,1000-16,1000-9,1000-10,1000-6,9000-9,6030-7,6080-4,3530-4,6000-4,1760-10,4000-4,1900-7,1600-17,1830000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47,100
0
-100
0
-100
0
45,100
0
46,600
0
45,700
0
0
0
103,700
0
269,500
247,300
247,300269,5000103,70000045,700046,600045,1000-1000-100047,100000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
226,946
310,596
49,432
49,432
49,432
49,432
155,275
155,275
155,275
155,275
181,976
181,976
181,976
181,976
200,277
200,277
200,277
200,277
217,121
217,121
217,121
217,121
246,087
246,087
246,087
982,624
269,808
1,074,978
269,808
1,077,190
253,856
1,072,800
253,856
1,012,837
231,563
1,053,200
231,563
924,214
243,435
937,364
243,435
971,499
266,975
980,300
266,975
1,065,200
306,400
1,132,000
306,400
1,222,500
340,550
1,255,100
340,550
1,358,900
383,975
1,398,100
383,975
1,525,400
460,850
1,665,300
460,850
1,841,100
438,250
1,981,300
438,250
1,751,000
530,450
1,857,100
530,450
2,119,100
688,500
2,386,600
688,500
2,751,500
834,175
3,064,500
834,175
3,337,300
0
3,404,300
3,825,100
3,825,1003,404,30003,337,300834,1753,064,500834,1752,751,500688,5002,386,600688,5002,119,100530,4501,857,100530,4501,751,000438,2501,981,300438,2501,841,100460,8501,665,300460,8501,525,400383,9751,398,100383,9751,358,900340,5501,255,100340,5501,222,500306,4001,132,000306,4001,065,200266,975980,300266,975971,499243,435937,364243,435924,214231,5631,053,200231,5631,012,837253,8561,072,800253,8561,077,190269,8081,074,978269,808982,624246,087246,087246,087217,121217,121217,121217,121200,277200,277200,277200,277181,976181,976181,976181,976155,275155,275155,275155,27549,43249,43249,43249,432310,596226,946
   Retained Earnings 
73,657
101,437
20,750
20,750
20,750
20,750
29,808
29,808
29,808
29,808
36,002
36,002
36,002
36,002
37,653
37,653
37,653
37,653
36,791
36,791
36,791
36,791
39,146
39,146
39,146
156,584
23,818
75,525
23,818
95,271
106
91,700
106
424
-7,373
90,200
-7,373
-29,491
38,135
96,230
38,135
152,540
38,375
104,000
38,375
153,500
47,475
90,100
47,475
189,900
56,475
133,000
56,475
225,900
68,075
125,900
68,075
272,300
97,375
197,500
97,375
389,500
-12,675
220,100
-12,675
-50,700
137,000
221,900
137,000
548,000
161,650
304,000
161,650
646,600
162,150
394,300
162,150
648,600
0
195,200
644,400
644,400195,2000648,600162,150394,300162,150646,600161,650304,000161,650548,000137,000221,900137,000-50,700-12,675220,100-12,675389,50097,375197,50097,375272,30068,075125,90068,075225,90056,475133,00056,475189,90047,47590,10047,475153,50038,375104,00038,375152,54038,13596,23038,135-29,491-7,37390,200-7,37342410691,70010695,27123,81875,52523,818156,58439,14639,14639,14636,79136,79136,79136,79137,65337,65337,65337,65336,00236,00236,00236,00229,80829,80829,80829,80820,75020,75020,75020,750101,43773,657
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-75,175
-75,175
-75,175
-300,699
-82,682
-320,099
-82,682
-330,728
-93,714
0
-93,714
-374,855
-91,381
0
-91,381
-365,522
-94,178
-376,082
-94,178
-376,710
-98,600
-380,200
-98,600
-394,400
-110,625
-432,900
-110,625
-442,500
-112,575
-441,800
-112,575
-450,300
-114,100
-460,900
-114,100
-456,400
-115,000
-462,800
-115,000
-460,000
-122,575
-451,900
-122,575
-491,400
-137,450
-522,400
-137,450
0
-160,625
0
-160,625
0
0
2,960,700
0
3,238,400
0
3,284,300
3,096,900
3,096,9003,284,30003,238,40002,960,70000-160,6250-160,6250-137,450-522,400-137,450-491,400-122,575-451,900-122,575-460,000-115,000-462,800-115,000-456,400-114,100-460,900-114,100-450,300-112,575-441,800-112,575-442,500-110,625-432,900-110,625-394,400-98,600-380,200-98,600-376,710-94,178-376,082-94,178-365,522-91,3810-91,381-374,855-93,7140-93,714-330,728-82,682-320,099-82,682-300,699-75,175-75,175-75,1750000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
122,300
0
122,300
0
1,983,900
0
122,300
0
2,547,400
0
3,093,000
0
03,093,00002,547,4000122,30001,983,9000122,3000122,300000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000-100,5000-102,100000000000-82,300-82,300-84,100-84,100-68,800-68,800-65,200-65,200-51,700-51,700-51,200-51,200-31,000-31,000-28,800-28,800-31,800-31,800-48,431-48,40000-38,216-38,216-39,822-39,822-38,600-38,600-39,632-39,632-41,070-41,070-42,214-42,214-40,230-40,230-41,451-41,451-35,336-35,336-31,547-31,5470-26,05200-1,2940000000000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,127,500
Cost of Revenue-571,200
Gross Profit2,556,3002,556,300
 
Operating Income (+$)
Gross Profit2,556,300
Operating Expense-1,575,300
Operating Income981,000981,000
 
Operating Expense (+$)
Research Development619,300
Selling General Administrative217,800
Selling And Marketing Expenses917,100
Operating Expense1,575,3001,754,200
 
Net Interest Income (+$)
Interest Income0
Interest Expense-19,400
Other Finance Cost-35,100
Net Interest Income-54,500
 
Pretax Income (+$)
Operating Income981,000
Net Interest Income-54,500
Other Non-Operating Income Expenses0
Income Before Tax (EBT)761,5001,200,500
EBIT - interestExpense = 961,600
780,600
663,800
Interest Expense19,400
Earnings Before Interest and Taxes (EBIT)981,000780,900
Earnings Before Interest and Taxes (EBITDA)1,068,900
 
After tax Income (+$)
Income Before Tax761,500
Tax Provision-136,200
Net Income From Continuing Ops619,900625,300
Net Income644,400
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,146,500
Total Other Income/Expenses Net-219,50054,500
 

Technical Analysis of Ipsen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ipsen. The general trend of Ipsen is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ipsen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ipsen SA.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 120.30 < 120.40 < 130.70.

The bearish price targets are: 111.50 > 110.60 > 110.50.

Tweet this
Ipsen SA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ipsen SA. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ipsen SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ipsen SA. The current macd is 1.37323932.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ipsen price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Ipsen. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Ipsen price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Ipsen SA Daily Moving Average Convergence/Divergence (MACD) ChartIpsen SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ipsen SA. The current adx is 15.20.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Ipsen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Ipsen SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ipsen SA. The current sar is 106.83.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Ipsen SA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ipsen SA. The current rsi is 63.47. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Ipsen SA Daily Relative Strength Index (RSI) ChartIpsen SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ipsen SA. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ipsen price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Ipsen SA Daily Stochastic Oscillator ChartIpsen SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ipsen SA. The current cci is 124.66.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Ipsen SA Daily Commodity Channel Index (CCI) ChartIpsen SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ipsen SA. The current cmo is 34.98.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Ipsen SA Daily Chande Momentum Oscillator (CMO) ChartIpsen SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ipsen SA. The current willr is -27.35849057.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ipsen is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Ipsen SA Daily Williams %R ChartIpsen SA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ipsen SA.

Ipsen SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ipsen SA. The current atr is 2.51101433.

Ipsen SA Daily Average True Range (ATR) ChartIpsen SA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ipsen SA. The current obv is -1,996,049.

Ipsen SA Daily On-Balance Volume (OBV) ChartIpsen SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ipsen SA. The current mfi is 50.56.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Ipsen SA Daily Money Flow Index (MFI) ChartIpsen SA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ipsen SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Ipsen SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ipsen SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.467
Ma 20Greater thanMa 50109.210
Ma 50Greater thanMa 100106.822
Ma 100Greater thanMa 200106.229
OpenGreater thanClose112.600
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ipsen with someone you think should read this too:
  • Are you bullish or bearish on Ipsen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ipsen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ipsen SA

I send you an email if I find something interesting about Ipsen SA.


Comments

How you think about this?

Leave a comment

Stay informed about Ipsen SA.

Receive notifications about Ipsen SA in your mailbox!